AAAAAA
Results: 101-120/120
Authors:
BROOKS KW
FOX TH
DAVIS LW
Citation: Kw. Brooks et al., A CRITICAL-LOOK AT CURRENTLY AVAILABLE RADIATION ONCOLOGY INFORMATIONMANAGEMENT-SYSTEMS, Seminars in radiation oncology, 7(1), 1997, pp. 49-57
Authors:
HERMAN MG
WILLIAMS AL
DICELLO JF
Citation: Mg. Herman et al., MANAGEMENT OF INFORMATION IN RADIATION ONCOLOGY - AN INTEGRATED SYSTEM FOR SCHEDULING, TREATMENT, BILLING, AND VERIFICATION, Seminars in radiation oncology, 7(1), 1997, pp. 58-66
Authors:
SHALEV S
Citation: S. Shalev, IMAGE STORAGE REQUIREMENTS FOR TREATMENT PLANNING AND VERIFICATION, Seminars in radiation oncology, 7(1), 1997, pp. 67-75
Authors:
RAGAN D
Citation: D. Ragan, OUTCOME ASSESSMENT IN RADIATION ONCOLOGY, Seminars in radiation oncology, 7(1), 1997, pp. 76-82
Authors:
HARMS WB
PURDY JA
Citation: Wb. Harms et Ja. Purdy, EVALUATING COMMERCIALLY AVAILABLE 3-DIMENSIONAL RADIOTHERAPY TREATMENT PLANNING SYSTEMS, Seminars in radiation oncology, 7(1), 1997, pp. 83-94
Authors:
SAUSE W
Citation: W. Sause, INTRODUCTION, Seminars in radiation oncology, 6(2), 1996, pp. 71-71
Authors:
MULSHINE JL
SCOTT F
ZHOU J
AVIS I
VOS M
MILLER MJ
SZABO E
MARTINEZ A
TRESTON AM
CUTTITTA F
TOCKMAN M
Citation: Jl. Mulshine et al., DEVELOPMENT OF MOLECULAR APPROACHES TO EARLY LUNG-CANCER DETECTION, Seminars in radiation oncology, 6(2), 1996, pp. 72-75
Authors:
RUSCH VW
Citation: Vw. Rusch, SURGICAL-TREATMENT OF PATIENTS WITH N2 DISEASE, Seminars in radiation oncology, 6(2), 1996, pp. 76-85
Authors:
KOMAKI R
Citation: R. Komaki, COMBINED CHEMOTHERAPY AND RADIATION-THERAPY IN SURGICALLY UNRESECTABLE REGIONALLY ADVANCED NONSMALL CELL LUNG-CANCER, Seminars in radiation oncology, 6(2), 1996, pp. 86-91
Authors:
EMAMI B
Citation: B. Emami, 3-DIMENSIONAL CONFORMAL RADIATION-THERAPY IN BRONCHOGENIC-CARCINOMA, Seminars in radiation oncology, 6(2), 1996, pp. 92-97
Authors:
DOSORETZ DE
KATIN MJ
BLITZER PH
RUBENSTEIN JH
GALMARINI DH
GARTON GR
SALENIUS SA
Citation: De. Dosoretz et al., MEDICALLY INOPERABLE LUNG-CARCINOMA - THE ROLE OF RADIATION-THERAPY, Seminars in radiation oncology, 6(2), 1996, pp. 98-104
Authors:
ROTH JA
MUKHOPADHYAY T
ZHANG WW
FUJIWARA T
GEORGES R
Citation: Ja. Roth et al., GENE REPLACEMENT STRATEGIES FOR LUNG-CANCER, Seminars in radiation oncology, 6(2), 1996, pp. 105-109
Authors:
BONOMI P
Citation: P. Bonomi, CHEMOTHERAPY FOR STAGE-IV NONSMALL CELL LUNG-CANCER - PROTOCOL VERSUSNONPROTOCOL - IS NONINVESTIGATIONAL TREATMENT WORTHWHILE - PATIENT SELECTION - WHICH REGIMEN - WHATS NEXT, Seminars in radiation oncology, 6(2), 1996, pp. 110-117
Authors:
RALEIGH JA
Citation: Ja. Raleigh, INTRODUCTION, Seminars in radiation oncology, 6(1), 1996, pp. 1-2
Authors:
HOCKEL M
SCHLENGER K
MITZE M
SCHAFFER U
VAUPEL P
Citation: M. Hockel et al., HYPOXIA AND RADIATION RESPONSE IN HUMAN TUMORS, Seminars in radiation oncology, 6(1), 1996, pp. 3-9
Authors:
OVERGAARD J
HORSMAN MR
Citation: J. Overgaard et Mr. Horsman, MODIFICATION OF HYPOXIA-INDUCED RADIORESISTANCE IN TUMORS BY THE USE OF OXYGEN AND SENSITIZERS, Seminars in radiation oncology, 6(1), 1996, pp. 10-21
Authors:
BROWN JM
SUM BG
Citation: Jm. Brown et Bg. Sum, HYPOXIA-SPECIFIC CYTOTOXINS IN CANCER-THERAPY, Seminars in radiation oncology, 6(1), 1996, pp. 22-36
Authors:
RALEIGH JA
DEWHIRST MW
THRALL DE
Citation: Ja. Raleigh et al., MEASURING TUMOR HYPOXIA, Seminars in radiation oncology, 6(1), 1996, pp. 37-45
Authors:
GIACCIA AJ
Citation: Aj. Giaccia, HYPOXIC STRESS PROTEINS - SURVIVAL OF THE FITTEST, Seminars in radiation oncology, 6(1), 1996, pp. 46-58
Authors:
SUTHERLAND RM
AUSSERER WA
MURPHY BJ
LADEROUTE KR
Citation: Rm. Sutherland et al., TUMOR HYPOXIA AND HETEROGENEITY - CHALLENGES AND OPPORTUNITIES FOR THE FUTURE, Seminars in radiation oncology, 6(1), 1996, pp. 59-70